PEDIATRICS Vol. 75 No. 3 March 1985, pp. 497-500
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maher, P.
Right arrow Articles by Clyman, R. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maher, P.
Right arrow Articles by Clyman, R. I.

Does Indomethacin Cause Extension of Intracranial Hemorrhages: A Preliminary Study

Patrick Maher MD1, Bart Lane MD1, Roberta Ballard MD1, Robert Piecuch MD1, and Ronald I. Clyman MD1

1 From the Department of Pediatrics, Mt Zion Hospital and Medical Center, San Francisco

Thirty-six infants who had an intracranial hemorrhage (diagnosed by cranial ultrasound) within four days after delivery (mean age 2.4 ± 0.9 [SD] days), were reexamined at three- to seven-day intervals for extension of their intracranial hemorrhage. Seventeen infants had a patent ductus arteriosus and were treated with indomethacin after the initial intracranial hemorrhage was diagnosed. The age for starting indomethacin was 3.8 ± 1.1 days. Nineteen infants did not have a patent ductus arteriosus and did not receive indomethacin. Both the indomethacin-treated and nontreated groups were similar in birth weight, gestational age, Apgar scores, gender, incidence of respiratory distress, as well as the location and the degree of hemorrhage in the initial scans. Only one of 17 (6%) infants who received indomethacin v two of 19 (11%) infants who did not receive it, had extension of their initial intracranial hemorrhage. orrhage. Although indomethacin may alter platelet function, it does not appear to cause extension of a preexisting intracranial hemorrhage.

Key Words: indomethacin • intracranial hemorrhage • patent ductus arteriosis • platelet dysfunction

Submitted on February 3, 1984
Accepted on May 1, 1984